The Impact of Air Travel on Passenger Cognitive Functions
NCT04802785, Phase 2, Phase 3, Unknown, Dinara Zhumanbayeva
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | The Impact of Air Travel on Passenger Cognitive Functions | ClinicalTrials.gov |
| NCT number | NCT04802785 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Phase 2, Phase 3 | ClinicalTrials.gov |
| Enrollment | 50 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Dinara Zhumanbayeva | ClinicalTrials.gov |
| Conditions | Air Travel | ClinicalTrials.gov |
| Interventions | Citicoline, Cytochrome C6, Sodium Chloride Oral Product, Potassium Chloride Oral Product, Sodium Citrate Oral Product, Dextrose Oral Tablet, Chewable, Domperidone Oral Product, Simethicone, Acetylsalicylic acid, Magnesium hydroxide, Probiotic Formula, Melatonin 5 mg | ClinicalTrials.gov |
| First posted | 2021-03-17 | ClinicalTrials.gov |
| Last updated | 2021-03-17 | ClinicalTrials.gov |
Registered outcomes 11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Urine Specific Gravity | 24 hours before the flight | Urine Specific Gravity test | ClinicalTrials.gov |
| Primary | SpO2 level | 24 hours before the flight | Pulse oximetry | ClinicalTrials.gov |
| Primary | Ultrasound examination | 24 hours before the flight | Ultrasound examination of the veins of the lower limbs | ClinicalTrials.gov |
| Primary | The Liverpool Jet Lag questionnaire | 24 hours before the flight | Changes from normal (0 to 5) while jetlag rating was recorded on a scale from 0 = insignificant jetlag to 10 = severe jetlag | ClinicalTrials.gov |
| Primary | Lake Louise Acute Mountain Sickness Assessment System | 24 hours before the flight | Mild acute mountain sicknessas 3-5 points, moderate acute mountain sickness as 6-9 points, and severe acute mountain sickness as 10-12 points | ClinicalTrials.gov |
| Primary | Neuropsychological tests (Trail Making Test, Wechsler Memory Scale - IV, Free recall | 24 hours after the flight | Word, color, and color-word T-Scores of 40 or less are considered "low." Word, color, and color-word T-Scores above 40 or are considered "normal." In order for one score to be considered "higher" or "lower" than another, a 10 point or greater T score difference is required. | ClinicalTrials.gov |
| Secondary | The Liverpool Jet Lag questionnaire (LJLQ) | 24 hours after the flight | Changes from normal (0 to 5) while jetlag rating was recorded on a scale from 0 = insignificant jetlag to 10 = severe jetlag | ClinicalTrials.gov |
| Secondary | Lake Louise Acute Mountain Sickness Assessment System | 24 hours after the flight | Mild acute mountain sicknessas 3-5 points, moderate acute mountain sickness as 6-9 points, and severe acute mountain sickness as 10-12 points | ClinicalTrials.gov |
| Secondary | The Stroop Test | 24 hours after the flight | Word, color, and color-word T-Scores of 40 or less are considered "low." Word, color, and color-word T-Scores above 40 or are considered "normal." In order for one score to be considered "higher" or "lower" than another, a 10 point or greater T score difference is required. | ClinicalTrials.gov |
| Secondary | Urine Specific Gravity | 24 hours after the flight | Urine Specific Gravity test | ClinicalTrials.gov |
| Secondary | SpO2 level | 24 hours before the flight | Pulse oximetry | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Trail Making Test A | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)